跳至主要内容
临床试验/EUCTR2019-001237-14-ES
EUCTR2019-001237-14-ES进行中(未招募)1 期

Randomized clinical trial, blinded for the researcher and multicenter, to evaluate the efficacy and safety of preoperative preparation with Lugol solution in euthyroid patients with Graves-Basedow disease.

Dr. Jesús María Villar del Moral and Dr. José Luis Muñoz de Nova0 个研究点目标入组 270 人开始时间: 2019年4月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
270

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • -The age of the patient must be over 18 years of age.
  • -The patient or his / her tutor, in cases where this is the case, has the capacity to understand the study and agrees to participate in it, by signing the corresponding informed consent document.
  • -Patients who have been diagnosed with GD, defined as the existence of hyperthyroidism (TSH < lower limit of laboratory normality associated with TSI > upper limit of laboratory normality) that present ultrasonographic data (diffuse vascularization increase) and / or scintigraphy (diffuse uptake of the radioisotope) compatible with EG.
  • -Euthyroid patients (free T4 and / or free T3 within the normal range of the laboratory) at the time of randomization, and under treatment with AT drugs (propylthiouracil, carbimazole or methimazole).
  • -The patient must be proposed for total thyroidectomy, using a transcervical approach.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • -Prior cervicotomy by surgical intervention on the thyroid or parathyroid gland.
  • -Associated hyperparathyroidism that requires associating a parathyroidectomy in the same surgical act.
  • -Associated thyroid cancer that requires adding a lymph node dissection of the central or lateral compartment in the same surgical time.
  • -Iodine allergy.
  • -Consumption of lithium or amiodarone between randomization and administration of SL.
  • -Patients with category IV of the anesthetic risk classification of the American Society of Anesthesiologists (ASA).
  • -Women who breastfeed during the administration of the LS or in the month after it.
  • -Preoperative palsy of a vocal cord verified by laryngoscopy.
  • -Surgery performed by training specialists, or by staff not specifically dedicated to endocrine surgery.
  • -Surgery not performed under general anesthesia.
  • -Endoscopic surgery, video assisted or by remote approach.
  • -Surgery performed in out-patient settings.
  • -Current drug consumption or alcohol abuse that could interfere with meeting the study requirements.
  • -Participation in any other trial with medications in the month prior to randomization.

研究者

发起方
Dr. Jesús María Villar del Moral and Dr. José Luis Muñoz de Nova

相似试验